Skip to main content
Journal ArticleOPEN ACCESS

Phase II Study of S-1 and Paclitaxel Combination Therapy in Patients with Previously Treated Non-Small Cell Lung Cancer

  • Chihara Y
  • Yoshimura A
  • Date K
  • et al.
The Oncologist (2019) 24(8) 1033-e617
DOI: 10.1634/theoncologist.2019-0290
7Citations
Citations of this article
26Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Lessons Learned: In terms of efficacy and safety, good results were obtained with S-1 and paclitaxel (PTX) combination therapy. The findings suggest that S-1 and PTX combination therapy is a feasible treatment option in patients with previously treated non-small cell lung cancer.

Cite

CITATION STYLE

APA

Chihara, Y., Yoshimura, A., Date, K., Takemura, Y., Tamiya, N., Kohno, Y., … Takayama, K. (2019). Phase II Study of S-1 and Paclitaxel Combination Therapy in Patients with Previously Treated Non-Small Cell Lung Cancer. The Oncologist, 24(8), 1033-e617. https://doi.org/10.1634/theoncologist.2019-0290

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free